Latest Healthcare It News

Page 14 of 142
Ansell Limited (ASX:ANN) reported a robust FY26 with net profit doubling to US$208.6 million, driven by strong sales growth and operational resilience amid geopolitical challenges. The company also announced a leadership change and reaffirmed its sustainability ambitions.
Victor Sage
Victor Sage
24 Aug 2026
Charter Hall Social Infrastructure REIT (ASX:CQE) posted a robust FY26 result with a 13.1% rise in operating earnings per unit, driven by strategic acquisitions and disciplined capital recycling. The portfolio now boasts a $2.3 billion valuation, near-full occupancy, and extended lease terms, underpinning income resilience amid ongoing sector demand.
Eva Park
Eva Park
21 Aug 2026
Charter Hall Long WALE REIT (ASX:CLW) reported steady operating earnings growth and reinforced its long WALE portfolio quality for FY26, alongside a $2 billion debt refinancing and enhanced sustainability credentials.
Eva Park
Eva Park
21 Aug 2026
Arena REIT reported an 8% rise in net operating profit to $79.1 million for FY2026, driven by rental growth and development completions, while facing uncertainty over its Edge Early Learning Portfolio due to rent defaults.
Eva Park
Eva Park
21 Aug 2026
Pro Medicus' US arm, Visage Imaging, has landed a substantial 7-year, A$25 million contract to deploy its Visage 7 cloud-based imaging platform across Valley Health's hospital network in Virginia and West Virginia.
Ada Torres
Ada Torres
21 Aug 2026
Fisher & Paykel Healthcare has raised its full-year net profit guidance for FY2027, buoyed by robust first-half sales and a $23 million US tariff refund. The medical devices maker forecasts up to 24% profit growth in H1, driven by hospital product demand and operational efficiencies.
Ada Torres
Ada Torres
21 Aug 2026
Excite Technology Services (ASX: EXT) has secured $3.122 million in sales over June and July 2026, bolstered by government contracts and private sector recurring revenue. The company is also tapping into a growing AI cybersecurity market with a pipeline exceeding $200,000.
Sophie Babbage
Sophie Babbage
20 Aug 2026
Memphasys has cleared a key regulatory hurdle in Vietnam for its Felix™ System, prompting a significant first commercial cartridge order and marking early clinical success in a fast-growing fertility market.
Ada Torres
Ada Torres
20 Aug 2026
Dexus (ASX: DXS) reported steady FY26 results with AFFO of 45.0 cents per security and distributions of 37.0 cents, while initiating a strategic review of infrastructure funds following an adverse APAC court judgment.
Eva Park
Eva Park
20 Aug 2026
NAOS Emerging Opportunities Company Limited (ASX: NCC) delivered a robust FY26 with a 2416% surge in after-tax profit and an 18.7% portfolio return, outperforming the benchmark by over 10%. The company raised its fully franked dividend by 5%, signaling confidence amid a challenging market.
Claire Turing
Claire Turing
20 Aug 2026
Artrya Limited marked its first full year of US commercial operations with a $25.18 million loss, driven by regulatory clearances, customer contracts, and an $80 million capital raise.
Ada Torres
Ada Torres
19 Aug 2026
EBOS Group posted a solid FY26, growing revenue nearly 10% to $13.5 billion and underlying EBITDA 5% to $614 million, while completing a major distribution centre renewal program. The company maintains its final dividend and sets a confident growth outlook for FY27.
Ada Torres
Ada Torres
19 Aug 2026

Browse the archive

Full archive